Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 73
Number of items: 73
  • Open Access
    Merino Tejero, E., Lashgari, D., García-Valiente, R., Gao, X., Crauste, F., Robert, P. A., Meyer-Hermann, M., Rodríguez Martínez, M., van Ham, S. M., Guikema, J. E. J., Hoefsloot, H., & van Kampen, A. H. C. (2021). Multiscale Modeling of Germinal Center Recapitulates the Temporal Transition From Memory B Cells to Plasma Cells Differentiation as Regulated by Antigen Affinity-Based Tfh Cell Help. Frontiers in Immunology, 11, Article 620716. https://doi.org/10.3389/fimmu.2020.620716
  • Open Access
    Beckman, W. F. (2021). The role of epigenetics in transcriptional stochasticity and the implications for breast cancer drug resistance. [Thesis, fully internal, Universiteit van Amsterdam].
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & Van Kampen, A. H. C. (2020). Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Springer Nature. https://doi.org/10.6084/m9.figshare.c.5067306.v1
  • Open Access
    Hasdemir, D., van den Berg, R. A., van Kampen, A., & Smilde, A. K. (2020). Modeling adaptive response profiles in a vaccine clinical trial. BMC Medical Research Methodology, 20, Article 191. https://doi.org/10.1186/s12874-020-01070-3
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P., & Van Kampen, A. H. C. (2020). Additional file 7 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.12673830.v1
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P., & Van Kampen, A. H. C. (2020). Additional file 4 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.12673821.v1
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & Van Kampen, A. H. C. (2020). Additional file 1 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.12673812.v1
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & Van Kampen, A. H. C. (2020). Additional file 13 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.12673803.v1
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P., & Van Kampen, A. H. C. (2020). Additional file 8 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.12673833.v1
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & Van Kampen, A. H. C. (2020). Additional file 10 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.12673794.v1
Page 2 of 8